Company Search:
Advanced Search
Sponsored Links
Tella Incorporation Company Snapshot
Tella Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tella Incorporation with three other companies in this sector in Japan: Symbio Pharmaceuticals Ltd (2015 sales of 1.93 billion Japanese Yen [US$16.74 million] of which 100% was Auxiliary Business), Medinet Co., Ltd. (1.67 billion Japanese Yen [US$14.50 million] of which 100% was cell processing), and Trans Genic Inc (1.96 billion Japanese Yen [US$16.96 million] ).

Sales Analysis. Tella Incorporation reported sales of ¥1.91 billion (US$16.54 million) for the year ending December of 2015. This represents an increase of 2.3% versus 2014, when the company's sales were ¥1.87 billion. Sales of Cell Therapy Support Business saw an increase that was more than double the company's growth rate: sales were up 10.0% in 2015, from ¥758.97 million to ¥834.86 million. Not all segments of Tella Incorporation experienced an increase in sales in 2015: sales of Cell Therapy Technology Development Busi fell 6.7% to ¥1.03 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tella Incorporation
  Stock Performance Chart for Tella Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 567.00
(Figures in Japanese Yen)
1 Week -2.7%   13 Weeks -6.3%  
4 Weeks -17.6%   52 Weeks -17.2%  
Tella Incorporation Key Data:
  Ticker: 2191 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 1,909,434,000
(Year Ending Jan 2016).
Employees: 91
  Currency: Japanese Yen Market Cap: 7,935,110,001
  Fiscal Yr Ends: December Shares Outstanding: 13,994,903
  Share Type: Common Closely Held Shares: 5,830,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.